Equities

Eli Lilly and Co

0Q1G:LSE

Eli Lilly and Co

  • Price (CHF)460.00
  • Today's Change460.00 / --
  • Shares traded3.00
  • 1 Year change--
  • Beta0.4034
Data delayed at least 20 minutes, as of Sep 03 2025 15:29 BST.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income10,5905,2406,245
Depreciation/depletion1,7671,5271,523
Non-Cash items4,5292,8682,004
Cash taxes paid, supplemental6,5625,5592,673
Cash interest paid, supplemental578404324
Changes in working capital(5385)(3055)(0.8)
Total cash from operations8,8184,2407,586
INVESTING
Capital expenditures(8404)(7392)(2985)
Other investing and cash flow items, total(898)239(778)
Total cash from investing(9302)(7153)(3763)
FINANCING
Financing cash flow items(491)(335)(309)
Total cash dividends paid(4680)(4069)(3536)
Issuance (retirement) of stock, net(2500)(750)(1500)
Issuance (retirement) of debt, net8,9018,650(62)
Total cash from financing1,2303,496(5407)
NET CHANGE IN CASH
Foreign exchange effects(297)169(168)
Net change in cash450752(1752)
Net cash-begin balance/reserved for future use2,8192,0673,819
Net cash-end balance/reserved for future use3,2682,8192,067
SUPPLEMENTAL INCOME
Depreciation, supplemental1,7671,5271,523
Cash interest paid, supplemental578404324
Cash taxes paid, supplemental6,5625,5592,673
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.